ArticleCancers2024

A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.

Karan Dixit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.